New Delhi: Delhi is fast emerging as a major hub in India’s illicit medicine black market—a shadow economy expanding rapidly despite repeated crackdowns. Investigations and recent enforcement actions indicate that the trade is not sporadic but deeply organised, operating through a well-oiled chain that stretches from illegal manufacturing units to chemists, wholesalers and ultimately unsuspecting patients.
Officials and public health experts warn that arrests alone are not enough to dismantle the network. The real challenge lies in fixing systemic gaps, particularly in supply chain monitoring, digital tracking and consumer awareness. Until the end user becomes alert and verification systems are actually used on the ground, the racket is unlikely to be contained.
According to investigators, the illegal trade operates in a structured, three-stage process. It begins at small warehouse units where expired medicines, rejected batches and low-cost raw drugs are stockpiled. In many cases, original packaging, such as strips and bottles, is salvaged and reused to give the products an appearance of authenticity.
The second stage involves repackaging and large-scale counterfeiting. Fake medicines are packed to resemble leading pharmaceutical brands, complete with forged holograms, labels and barcodes. While the government has mandated QR codes for traceability, the system is being manipulated. Counterfeiters are generating forged QR codes that appear genuine and are often linked to cloned or misleading data. Officials admit that compliance remains weak, with many chemists not scanning codes and supply chain data not being consistently updated. In rural areas, verification mechanisms are even more limited, allowing fake drugs to pass unchecked.
In the final stage, these medicines are pushed into wholesale markets, small pharmacies and even hospitals. Investigators say that in several instances, licensed traders have also been found complicit, drawn by high profit margins in the illegal trade.
A string of recent crackdowns highlights the scale and sophistication of the racket. On April 24, the Delhi Police Crime Branch busted an international psychotropic drug smuggling syndicate operating through courier services, where fake invoices, masked batch numbers and digital payment trails exposed shipments being sent to the United States. On April 20, a raid in East Delhi’s Madhu Vihar uncovered a unit manufacturing counterfeit ENO antacid and fake Nescafé products worth nearly ₹20 lakh from residential flats. On April 15, thousands of fake Veet products were seized and four persons arrested for running an organised counterfeit network targeting unsuspecting consumers.
Earlier, between February and March 2026, the Central Drugs Standard Control Organisation seized large quantities of fake antibiotics such as Amoxicillin and liver medicines falsely branded under reputed companies during raids in Delhi and Uttar Pradesh. In January 2025, illicit medicines worth ₹8 crore were seized in Delhi, with a doctor identified as the alleged mastermind supplying hospitals across NCR. In December 2024, more than ₹5 lakh worth of fake cancer, kidney and liver drugs were recovered from Bhagirath Place. In April 2024, counterfeit cancer and diabetes medicines worth over ₹4 crore were seized, with criminals found copying original holograms to pass off fake products as genuine.
Regulators acknowledge that fake and substandard drugs remain a serious and persistent threat. CDSCO alone flagged multiple suspected spurious drug batches in February 2026, pointing to continuing vulnerabilities in the system. Experts say the current enforcement-driven approach is largely reactive and fails to address structural weaknesses. Without real-time digital tracking, strict compliance across the supply chain and accountability at every level, counterfeiters continue to exploit loopholes.
At the end of this chain is the patient, often unaware of the danger. Low awareness and lack of vigilance make it easier for counterfeit medicines to circulate. Experts advise consumers to carefully examine packaging for spelling errors, poor print quality or tampering, verify manufacturer details and batch numbers, avoid unusually low-priced products, and always purchase medicines from licensed pharmacies with a proper bill. They also stress the importance of scanning QR codes and reporting suspicious drugs through official platforms.
The spread of fake medicines is not merely an economic offence but a growing public health crisis. Substandard or counterfeit drugs can lead to treatment failure, drug resistance and even death. Unless systemic reforms are enforced—from manufacturing surveillance to last-mile verification—the illicit trade will continue to thrive in the gaps between regulation and reality, putting millions of lives at risk.
(Cover Image: AI Generated)
